Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Jamaica Hospital Medical Center Bristol-Myers Squibb JHMC Department of Psychiatry, Research Division Jamaica Hospital Medical Center Department of Psychiatry |
---|---|
Information provided by: | Jamaica Hospital Medical Center |
ClinicalTrials.gov Identifier: | NCT00374348 |
To evaluate the effectiveness of flexible doses (15-30mg) of Aripiprazole in the treatment of patients with schizophrenia and co-morbid symptoms of OCD in the outpatient setting. The overall effectiveness of Aripiprazole will be evaluated by use of the Brief Psychiatric Rating Scale(BPRS), Yale-Brown OCD scale and Clinical Global Impression-Improvement(CGI-I) scale.
Condition | Intervention |
---|---|
Schizophrenia Obsessive Compulsive Disorder |
Drug: Aripiprazole |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | "Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)". |
Estimated Enrollment: | 10 |
Study Start Date: | March 2005 |
Estimated Study Completion Date: | September 2005 |
Symptoms of OCD is a rather common co-morbid condition in patients with Schizophrenia. Some studies suggest that obsessive-compulsive symptoms may be present in 7.8-46% of schizophrenic patients and who seem to be poorly responsive to drug therapy. The serotonergic medications in combination with cognitive-behavioral therapy stil remain the preferred treatment for OCD symptoms. There are controversial data regarding effect of neuroleptics on symptoms of OCD. It was noted that the use of Risperdone, Quatiapine and Clozapine might aggravate OCD symptoms. Serotonin antagonism of these neuroleptics is believed to exacerbate obsessive-compulsive symptoms in schizophrenia. On the other hand, Pourovsky M. at(2000) reported three cases of Schizophrenia with symptoms of OCD successfully treated with Olanzapine.One of our patients with Schizophrenia and co-morbid symptoms of OCD who was unsuccessfully treated with various neuroleptics in combination with anti-obsessive agents,demonstrated significant improvement in both Schizophrenic and obsessive compulsive symptoms after she was switched to Aripiprazole. This result encouraged us to initiate pilot study of effectiveness of Aripiprazole in the treatment of specific population of schizophrenic patients with symptoms of OCD.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Isak Isakov, M.D. | (718) 206-7311 ext 7300 | iisakov@earthlink.com |
United States, New York | |
Jamaica Hospital Medical Center Department of Psychiatry | Recruiting |
Jamaica, New York, United States, 11418 | |
Principal Investigator: Isak Isakov, M.D. |
Principal Investigator: | Isak Isakov, M.D. | Jamaica Hospital Medical Center |
Study ID Numbers: | JH-PSY-Aripiprazole/Schiz/OCD |
Study First Received: | September 7, 2006 |
Last Updated: | September 8, 2006 |
ClinicalTrials.gov Identifier: | NCT00374348 |
Health Authority: | United States: Institutional Review Board |
Schizophrenia with OCD Schizophrenia and-comorbid symptoms of Obsessive Compulsive Disorder(OCD) |
Schizophrenia Anxiety Disorders Mental Disorders Psychotic Disorders |
Aripiprazole Schizophrenia and Disorders with Psychotic Features Obsessive-Compulsive Disorder |
Tranquilizing Agents Pathologic Processes Disease Therapeutic Uses Physiological Effects of Drugs |
Psychotropic Drugs Central Nervous System Depressants Antipsychotic Agents Central Nervous System Agents Pharmacologic Actions |